Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.
Tiejun YangYifeng JingJun DongXinpei YuMingming ZhongLaura E PascalDan WangZhongxian ZhangBaoping QiaoZhou WangPublished in: The Prostate (2018)
Our findings provide further evidence that ELL2 is a potential tumor suppressor frequently down-regulated in clinical prostate cancer specimens and provides new insights into regulation of ELL2 protein level by polyubiquitination and EAF2 binding.